<SEC-DOCUMENT>0001493152-25-012596.txt : 20250904
<SEC-HEADER>0001493152-25-012596.hdr.sgml : 20250904
<ACCEPTANCE-DATETIME>20250904060515
ACCESSION NUMBER:		0001493152-25-012596
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250903
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250904
DATE AS OF CHANGE:		20250904

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MOBIX LABS, INC
		CENTRAL INDEX KEY:			0001855467
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				981591717
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40621
		FILM NUMBER:		251291828

	BUSINESS ADDRESS:	
		STREET 1:		15420 LAGUNA CANYON RD, STE 100
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		(949) 808-8888

	MAIL ADDRESS:	
		STREET 1:		15420 LAGUNA CANYON RD, STE 100
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Chavant Capital Acquisition Corp.
		DATE OF NAME CHANGE:	20210406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:MOBX="http://mobixlabs.com/20250903">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_MOBX_mobixlabs.com_20250903 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20250903_20250903 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001855467 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000004" name="dei:EntityCentralIndexKey">0001855467</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="mobx-20250903.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001855467</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-03</xbrli:startDate>
        <xbrli:endDate>2025-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001855467</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MOBX:ClassCommonStockParValue0.00001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-03</xbrli:startDate>
        <xbrli:endDate>2025-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001855467</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MOBX:RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-03</xbrli:startDate>
        <xbrli:endDate>2025-09-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_904_edei--DocumentType_c20250903__20250903_z2zVcdba7Uo1"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d)<br/>
OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_90E_edei--DocumentPeriodEndDate_c20250903__20250903_zY6x6jslxEVf"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 3, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20250903__20250903_ztRfIBKXQ3q9"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000011" name="dei:EntityRegistrantName">MOBIX
LABS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20250903__20250903_zmMCMfEnBWt2"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20250903__20250903_ztnhWa6rl2Jl"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000013" name="dei:EntityFileNumber">001-40621</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20250903__20250903_z6OxyKqyf4cf"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-1591717</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 68%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20250903__20250903_zyanyBk7zY27"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000015" name="dei:EntityAddressAddressLine1">1
                                            Venture</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20250903__20250903_z1tnC0efY8je"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 220</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20250903__20250903_zx9SwPY4utv9"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000017" name="dei:EntityAddressCityOrTown">Irvine</ix:nonNumeric></span>,
    <span id="xdx_906_edei--EntityAddressStateOrProvince_c20250903__20250903_z74lSI3MU90i"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressPostalZipCode_c20250903__20250903_z6B5QpQyKUU1"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000019" name="dei:EntityAddressPostalZipCode">92618</ix:nonNumeric></span></b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_90B_edei--CityAreaCode_c20250903__20250903_zcRF25pwRP5f"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000020" name="dei:CityAreaCode">(949)</ix:nonNumeric></span> <span id="xdx_907_edei--LocalPhoneNumber_c20250903__20250903_zf1LbuGtRFKb"><ix:nonNumeric contextRef="AsOf2025-09-03" id="Fact000021" name="dei:LocalPhoneNumber">808-8888</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20250903__20250903_z7lfjpWabz3d"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--SolicitingMaterial_c20250903__20250903_z289sBJQOULj"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20250903__20250903_zVCWhEDrf437"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))&#8239;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20250903__20250903_zkaN8PDBdWW4"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20250903__20250903__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.00001PerShareMember_z1c72ycLP6P1"><ix:nonNumeric contextRef="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember" id="Fact000026" name="dei:Security12bTitle">Class
    A Common Stock, par value $0.00001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20250903__20250903__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.00001PerShareMember_z5mIPdhRiDik"><ix:nonNumeric contextRef="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember" id="Fact000027" name="dei:TradingSymbol">MOBX</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SecurityExchangeName_c20250903__20250903__us-gaap--StatementClassOfStockAxis__custom--ClassCommonStockParValue0.00001PerShareMember_zmshf2Vith16"><ix:nonNumeric contextRef="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20250903__20250903__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember_z0UiorEyY5oj"><ix:nonNumeric contextRef="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" id="Fact000029" name="dei:Security12bTitle">Redeemable
    warrants, each warrant exercisable for one share of Class A Common Stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20250903__20250903__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember_zVZXzXkiRXWc"><ix:nonNumeric contextRef="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" id="Fact000030" name="dei:TradingSymbol">MOBXW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_90B_edei--SecurityExchangeName_c20250903__20250903__us-gaap--StatementClassOfStockAxis__custom--RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember_zWsGF3fqlkgh"><ix:nonNumeric contextRef="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_907_edei--EntityEmergingGrowthCompany_c20250903__20250903_zzk5fvkyr5V7"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt:booleantrue" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90A_edei--EntityExTransitionPeriod_c20250903__20250903_zD29NXh41iIa"><ix:nonNumeric contextRef="AsOf2025-09-03" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
    into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2025, Mobix Labs, Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into a warrant exercise inducement offer
letter (the &#8220;Inducement Letter&#8221;) with a holder (the &#8220;Holder&#8221;) of warrants to purchase shares of the Company&#8217;s
common stock (the &#8220;Existing Warrants&#8221;) pursuant to which the Holder agreed to exercise for cash their Existing Warrants to
purchase up to an aggregate of 5,486,467 shares of the Company&#8217;s common stock, consisting of (i) 1,484,953 shares of the Amended
and Restated Series A Common Stock purchase warrants (the &#8220;Series A Warrant Shares&#8221;), (ii) 1,484,953 shares of the Amended
and Restated Series B Common Stock purchase warrants (the &#8220;Series B Warrant Shares&#8221;), and (iii) 2,516,562 shares of the Common
Stock purchase warrants (the &#8220;Common Stock Warrant Shares&#8221; and together with the Series A Warrant Shares and the Series B
Warrant Shares, the &#8220;Existing Warrant Shares&#8221;), at the current exercise price of $0.8202 per share, in exchange for the Company&#8217;s
agreement to issue new warrants (the &#8220;Inducement Warrants&#8221;) as described
below, to purchase up to an aggregate of 8,229,701 shares of the Company&#8217;s common stock (the &#8220;Inducement Warrant Shares&#8221;).
The Company expects to receive aggregate gross proceeds of approximately $4.5 million from the exercise of the Existing Warrants by the
Holder. The Company engaged Roth Capital Partners, LLC (&#8220;Roth&#8221;) to act as its financial advisor in connection with the transactions
summarized above and will pay Roth a cash placement fee equal to 7.0% of the aggregate gross proceeds and will issue warrants to purchase
up to 384,053 shares of the Company&#8217;s common stock (the &#8220;Placement Agent Warrants&#8221;) (which represents 7.0% of
the sum of the Existing Warrants exercised) at an exercise price of $1.08.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of the Company&#8217;s common stock issuable upon exercise of the Existing Warrants are registered for resale by the Holder pursuant
to an existing registration statement on Form S-1 (File No. 333-287493) declared effective by the Securities and Exchange Commission
(the &#8220;SEC&#8221;) on August 11, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also agreed to file a registration statement on Form S-3 (or other appropriate form, including on Form S-1, if the Company is
not then Form S-3 eligible) covering the resale of the Inducement Warrants Shares issued or issuable upon the exercise of the Inducement
Warrants (the &#8220;Resale Registration Statement&#8221;) within thirty (30) calendar days of the date of the Inducement Letter. In
the Inducement Letter, the Company agreed not to issue any shares of common stock or common stock equivalents or to file any other registration
statement with the SEC (in each case, subject to certain exceptions) for forty-five (45) days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed to hold an annual or special meeting of stockholders on or prior to the date that is sixty (60) calendar days after
the Closing Date (as defined in the Inducement Letter) for the purpose of obtaining stockholder approval, with the recommendation of
the Company&#8217;s board of directors that such proposals are approved. If the Company does not obtain stockholder approval at the first
meeting, the Company has agreed to call a meeting to seek stockholder approval every sixty (60) calendar days until the date that the
Inducement Warrants are no longer outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inducement
Warrant Terms</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the Inducement Warrants is not complete and is subject to, and qualified in its
entirety by, the provisions of the Inducement Warrants, the form of which is filed as Exhibit 4.1 to this Current Report on Form 8-K
and is incorporated herein by reference. The following description of the Inducement Warrants is qualified in its entirety by reference
to such exhibit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration
and Exercise Price</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Inducement Warrant will have an exercise price equal to $1.08 per share. The Inducement Warrants will be exercisable upon stockholder
approval and may be exercised until the fifth (5th) anniversary of the initial exercise date. The exercise price and number of shares
of common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations
or similar events affecting our common stock and the exercise price. The Inducement Warrants will be issued in certificated form only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Inducement Warrants will be exercisable, at the option of the holder, in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise (except in the case of
a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such holder&#8217;s
Inducement Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock immediately after exercise,
except that upon at least 61 days&#8217; prior notice from the holder to us, the holder may increase the amount of ownership of outstanding
stock after exercising the holder&#8217;s Inducement Warrants up to 9.99% of the number of shares of our common stock outstanding immediately
after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Inducement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its Inducement Warrants, a registration statement registering the issuance of the shares of common stock
underlying the Inducement Warrants under the Securities Act is not then effective or available for the issuance of such shares, then
in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price,
the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined
according to a formula set forth in the Inducement Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transactions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of any fundamental transaction, as described in the Inducement Warrants and generally including any merger with or into another
entity, sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our common stock, then
upon any subsequent exercise of an Inducement Warrant, the holder will have the right to receive as alternative consideration, for each
share of our common stock that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental transaction,
the number of shares of common stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of our common
stock for which the Inducement Warrant is exercisable immediately prior to such event. Notwithstanding the foregoing, in the event of
a fundamental transaction, the holders of the Inducement Warrants have the right to require us or a successor entity to redeem the Inducement
Warrants for cash in the amount of the Black Scholes Value (as defined in each Inducement Warrant) of the unexercised portion of the
Inducement Warrants concurrently with or within 30 days following the consummation of a fundamental transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
in the event of a fundamental transaction which is not in our control, including a fundamental transaction not approved by our board
of directors, the holders of the Inducement Warrants will only be entitled to receive from us or our successor entity, as of the date
of consummation of such fundamental transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes
Value of the unexercised portion of the Inducement Warrant that is being offered and paid to the holders of our common stock in connection
with the fundamental transaction, whether that consideration is in the form of cash, stock or any combination of cash and stock, or whether
the holders of our common stock are given the choice to receive alternative forms of consideration in connection with the fundamental
transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable securities laws and conditions set forth in the Inducement Warrants and the Inducement Letter, an Inducement Warrant may
be transferred at the option of the holder upon surrender of the Inducement Warrant to us together with the appropriate instruments of
transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fractional
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of common stock will be issued upon the exercise of the Inducement Warrants. Rather, the number of shares of common
stock to be issued will, at our election, either be rounded up to the next whole share or we will pay a cash adjustment in respect of
such final fraction in an amount equal to such fraction multiplied by the exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trading
Market</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established trading market for the Inducement Warrants, and we do not expect an active trading market to develop. We do not intend
to apply to list the Inducement Warrants on any securities exchange or other trading market. Without a trading market, the liquidity
of the Inducement Warrants will be extremely limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Right
as a Stockholder</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the Inducement Warrants or by virtue of the holder&#8217;s ownership of shares of our common stock, such holder
of Inducement Warrants does not have the rights or privileges of a holder of our common stock, including any voting rights or dividends,
until such holder exercises such holder&#8217;s Inducement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Waivers
and Amendments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Inducement Warrant may be modified or amended or the provisions of the Inducement Warrant waived with our and the holder&#8217;s written
consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has also agreed to amend the Series B Warrants held by the Holder and not exercised pursuant to the Inducement Letter in order
to extend the Termination Date (as defined in the Series B Warrants) to be equal to April 3, 2030.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forms of Inducement Letter and Inducement Warrant are attached as Exhibits 10.1 and 4.1, respectively. The descriptions of the terms
of the Inducement Letter and the Inducement Warrants are not intended to be complete and are qualified in its entirety by reference to
such exhibits. The Inducement Letter contains customary representations, warranties and covenants by the Company which were made only
for the purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements, and may
be subject to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    3.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
    Sales of Equity Securities.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued the Inducement Warrants, the Existing Warrant Shares and the Placement Agent Warrants pursuant to the exemption
from the registration requirements of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), available under Section
4(a)(2) and/or Rule 506(b) of Regulation D promulgated thereunder and intends to issue the Inducement Warrant Shares and shares issuable
upon exercise of the Placement Agent Warrants pursuant to the same exemption or pursuant to the exemption provided by Section 3(a)(9)
of the Securities Act. The description of the Inducement Warrants and the Placement Agent Warrants under Item 1.01 of this Form
8-K is incorporated by reference herein. The form of the Inducement Warrant and Placement Agent Warrant has been filed as an exhibit
to this Form 8-K and is incorporated by reference herein</span>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
    FD</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2025, the Company issued a press release disclosing the transactions described herein, a copy of which is furnished as Exhibit
99.1 to this Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exhibits</i>.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    No.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form of Inducement Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of Amended and Restated Series B Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">4.3</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="ex4-3.htm">Form of Placement Agent Warrant</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Inducement Letter</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release, dated September 3, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mobix
Labs, Inc.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    4, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Keyvan Samini</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keyvan
    Samini</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">President and Chief Financial Officer</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1Ue9ugjAQfwLf4UL2kWjBuGR8cwTNMp0EjdvXCsckQo9c8d8j7S1XisRkcU2T9nr3+3NXx3GdOc2KEhm+XpMFbLCqS9kgJJgjo0rRVIRv7wGYM8HvQjcsVWPDHhiSwaDBPA+9nXm3ladCYxaAeBmJ8cifgPCC8QTipTNo8yGpvMhQNYUsQaoMYqaaC2wkXzuGjbyQoupqlbbIuiAVgDcUXfoHfOH58EEneSY+aFgsQmfg2jVw5kzH2lRFlwZVi4SoxMrI6Q5939ZNetQNVUGCGWIldyV+Sm671JFM97d7dEFOC91mZ8Qrheu9ZFzlYSm1NhOoSK0bSg9LrHbIhtQTvu+JqegH0nPD+UbuAhr6PgS8C0BODKQQdKsBlINVgSl0QmCVHnTw10wseSvLI4qhMMuLka3rfzw+EnGhlgynlgSebjRQm0+31noLv/F0tSM= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>mobix
labs, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [______]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: September 4, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [______] or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on the
date that is five (5) years from the Stockholder Approval Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from Mobix Labs, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [______] shares (as subject
to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under
this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>.&#9;<U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Class A common stock of the Company, par value $0.00001 per share, and any other class of securities into
which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Letter
Agreement</U>&rdquo; means the letter agreement, dated as of September 3, 2025 by and between the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the stockholders of the Company with respect to issuance of all of the Warrants and the Warrant Shares upon the
exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer, the current transfer agent of the Company, with a mailing address of 1 State Street
30<SUP>th</SUP> Floor, , New York, New York 10004-1561 and an email address of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ], and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>.&#9;<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares
purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any
Notice of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>1.08, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered pursuant to Section
    2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
    NMS promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of the Common Stock on the principal
    Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) within two (2) hours of the time of the Holder&rsquo;s
    delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular
    trading hours,&rdquo; or with two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or (iii) the
    VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
    Exercise is delivered pursuant to Section 2(a) hereof after two (2) hours following the close of &ldquo;regular trading hours&rdquo;
    on such Trading Day;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of
(i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the
earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of
the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be [9.99/4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise
of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>.&#9;<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">c)
<U></U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Rata Distributions</FONT></U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without
limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater
than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company
or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental
Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock
are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity may be the
Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value
of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as
of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility,
(2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined
utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated
Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price
per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction
and (ii) the VWAP immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and (D) a remaining option time equal to the time between the date of the public
announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment
of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later
of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Stockholder
Approval</U>. The Company shall use its reasonable best efforts to hold a special meeting of stockholders on or prior to sixty (60) days
after the Closing Date (as defined in the Letter Agreement), for the purpose of obtaining the Stockholder Approval, with the recommendation
of the Company&rsquo;s Board of Directors that such proposal be approved, and the Company shall solicit proxies from its stockholders
in connection therewith in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders
shall vote their proxies in favor of such proposal. The Company shall use its reasonable best efforts to obtain such Shareholder Approval.
If the Company does not obtain Stockholder Approval at the first meeting, the Company shall call a meeting every sixty (60) days thereafter
to seek Stockholder Approval until the earlier of the date on which Stockholder Approval is obtained or this Warrant is no longer outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>.&#9;<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and the Letter Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. <FONT STYLE="text-decoration-style: double">Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date
on which the Holder delivers an assignment form to the Company assigning this Warrant in full. </FONT>The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">d)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer Restrictions</U>. <FONT STYLE="text-decoration-style: double">If</FONT>,
at the <FONT STYLE="text-decoration-style: double">time of the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be either (i) registered pursuant to an effective </FONT>registration <FONT STYLE="text-decoration-style: double">statement
under the Securities Act</FONT> and <FONT STYLE="text-decoration-style: double">under applicable state securities or blue sky laws or
(ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144,
the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be,
</FONT>provides to the Company an opinion of counsel, the form and substance of which opinion shall be reasonably satisfactory to the
Company, to the effect that the transfer of this Warrant does not require registration under the Securities Act<FONT STYLE="text-decoration-style: double">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>.&#9;<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Letter Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at _____________, _______, Attention: _________, email address: ___________, or such other email address or
address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries
to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice
or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if
such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City
time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail
at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any
Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder
constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, as determined by the Company in
consultation with Company Counsel, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>mobix labs, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">mobix labs, inc.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: <U></U>________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address: _________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECOND
AMENDED AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SERIES
B COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Mobix
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [_____]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Issue Date: September 4, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1<SUP>st</SUP>
    Amendment Date: April 7, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
    Issue Date: July 24, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SERIES B COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [__________] or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to
5:00 p.m. (New York City time) April 3, 2030, provided that, if such date is not a Trading Day, the date that is the immediately following
Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Mobix Labs, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), up to [_________] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b). The Company and the Holder each acknowledges and agrees that this Warrant amends and restates in its
entirety and replaces that certain Amended and Restated Series B Common Stock Purchase Warrant that was issued by the Company to the
Holder on April 7, 2025 in connection with an amendment to that certain Series B Common Stock Purchase Warrant that was originally issued
by the Company to the Holder on July 24, 2024 , which is deemed cancelled as of the date hereof. Pursuant to Rule 144, the holding period
of this Warrant shall tack back to July 24, 2024. For the purposes of this Warrant, &ldquo;<U>Stockholder Approval</U>&rdquo; means such
approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from the stockholders
of the Company with respect to issuance of this Warrant and the Warrant Shares upon the exercise hereof and &ldquo;<U>Stockholder Approval
Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated April 4, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.8202</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="width: 0.25in">(A)
</TD>
    <TD STYLE="text-align: center; width: 0.1in">= </TD>
  <TD STYLE="text-align: justify">as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) the Bid Price of the Common Stock on the principal Trading
Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable
Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day)
pursuant to Section 2(a) hereof, or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>(B)</TD>
    <TD STYLE="text-align: center">= </TD>
  <TD STYLE="text-align: justify">the Exercise
Price of this Warrant, as adjusted hereunder; and</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>(X)</TD>
    <TD STYLE="text-align: center">= </TD>
  <TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (the &ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX
Best Market (the &ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading
on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market operated by the OTC Markets, Inc. (the
&ldquo;<U>Pink Market</U>&rdquo;) (or a similar organization or agency succeeding to its functions of reporting prices), the most recent
bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB or the OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market, the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Mechanics
of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the number of Trading Days comprising
the Standard Settlement Period, after the delivery to the Company of the Notice of Exercise and subject to delivery of the aggregate
Exercise Price to the Company (if applicable) prior to such date (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon
delivery of the Notice of Exercise the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that
payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date.
If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share
Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares
subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day
(increasing to $20 per Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice to the
Company at any time prior to the delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of, and shall be the sole responsibility of, the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for purported or actual exercises of this Warrant that are not in compliance with the Beneficial Ownership
Limitation (other than to the extent that information on the number of outstanding shares of Common stock of the Company is provided
by the Company and relied upon by the Holder). In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder and the Company shall have
no obligation to verify or confirm the accuracy of such determination and shall have no liability for purported or actual exercises of
this Warrant that are not in compliance with the Beneficial Ownership Limitation (other than to the extent that information on the number
of outstanding shares of Common Stock of the Company is provided by the Company and relied upon by the Holder). For purposes of this
Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares
of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case
may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding. Upon the written request of a Holder, the Company shall within one (1)
Trading Day confirm in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The
Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided
that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section
2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation); and provided, further, however, that Holder shall not be entitled to participate in any
such Distribution to the extent such Distribution constitutes a Fundamental Transaction and the provisions of Section 3(d) below are
applicable to such Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person (excluding a merger effected solely to change the Company&rsquo;s
name or domiciliation), (ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, exclusive license, assignment,
transfer, conveyance or other disposition of all or substantially all of the assets of the Company in one or a series of related transactions,
(iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater than 50% of the voting power of the
common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group
acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the common equity of the
Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have
the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of
such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant),
the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination
of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however,
that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of
Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration
(and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to
the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form
of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received
common stock of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental
Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model
obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time
between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected
volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C)
the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash, if any, plus the
value of any non-cash consideration, if any, being offered in such Fundamental Transaction, (D) a remaining option time equal to the
time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and
(E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such
other consideration) within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably
satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at
the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of
shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior
to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon
the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this
Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant
and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the
Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume
all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if
the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding. Notwithstanding the foregoing, in no event
may the Exercise Price be adjusted below the par-value of the Common Stock then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Voluntary
Adjustment By Company</U>. Subject to Stockholder Approval and the rules and regulations of the Trading Market, the Company may at any
time during the term of this Warrant, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate
by the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Original Issue Date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant, if the Company willfully
and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall
pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo;
fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise
enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Amended and Restated Warrant to be executed by its officer thereunto duly authorized as
of the date first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Mobix
    Labs, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To: <B>Mobix
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ________________________<U>       </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: _________________________<U>       </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ex4-3.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>mobix
labs, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [____]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: September 4, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_________] or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on the date that is five (5) years from the Stockholder Approval Date (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Mobix Labs, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up
to [______] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Class A common stock of the Company, par value $0.00001 per share, and any other class of securities into
which such securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Letter
Agreement</U>&rdquo; means the letter agreement, dated as of September 3, 2025 by and between the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the stockholders of the Company with respect to issuance of all of the Warrants and the Warrant Shares upon the
exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer, the current transfer agent of the Company, with a mailing address of 1 State Street
30<SUP>th</SUP> Floor, New York, New York 10004-1561 and an email address of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date
on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares
purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any
Notice of Exercise on the Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>1.08, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof
                                            on a day that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a
                                            Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule
                                            600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day,
                                            (ii) the highest Bid Price of the Common Stock on the principal Trading Market as reported
                                            by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) within two (2) hours of the time of the
                                            Holder&rsquo;s delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such
                                            Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo; or with two (2)
                                            hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day or (iii) the
                                            VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise
                                            is a Trading Day and such Notice of Exercise is delivered pursuant to Section 2(a) hereof
                                            after two (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance
                                            with the terms of this Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of
(i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the
earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of
the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be [9.99/4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of
Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise
of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater
than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the
public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount
of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company
or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental
Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock
are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <U>provided</U>,
<U>further</U>, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction,
such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity may be the
Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value
of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as
of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility,
(2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined
utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated
Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price
per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction
and (ii) the VWAP immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation
of the applicable Fundamental Transaction, if earlier) and (D) a remaining option time equal to the time between the date of the public
announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment
of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later
of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the
Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form
and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or
its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to
any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Stockholder
Approval</U>. The Company shall use its reasonable best efforts to hold a special meeting of stockholders on or prior to sixty (60) days
after the Closing Date (as defined in the Letter Agreement), for the purpose of obtaining the Stockholder Approval, with the recommendation
of the Company&rsquo;s Board of Directors that such proposal be approved, and the Company shall solicit proxies from its stockholders
in connection therewith in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders
shall vote their proxies in favor of such proposal. The Company shall use its reasonable best efforts to obtain such Shareholder Approval.
If the Company does not obtain Stockholder Approval at the first meeting, the Company shall call a meeting every sixty (60) days thereafter
to seek Stockholder Approval until the earlier of the date on which Stockholder Approval is obtained or this Warrant is no longer outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and the Letter Agreement,
this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, provides to the Company an opinion of counsel, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that the transfer of this Warrant does not require registration under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Letter Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any
Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service,
addressed to the Company, at _____________, _______, Attention: _________, email address: ___________, or such other email address or
address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries
to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice
or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if
such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City
time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail
at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any
Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder
constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, as determined by the Company in
consultation with Company Counsel, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>mobix labs, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">mobix labs, inc.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT>______________________________________</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none"> ______________________________________</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:______________________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:_______________________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Mobix
labs, inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 328.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
3, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder
of Common Stock Purchase Warrants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inducement
    Offer to Exercise Common Stock Purchase Warrants</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mobix
Labs, Inc. (the &ldquo;<U>Company</U>&rdquo;) is pleased to offer to you (&ldquo;<U>Holder</U>&rdquo;, &ldquo;<U>you</U>&rdquo; or similar
terminology) the opportunity to receive new warrants to purchase shares of the Company&rsquo;s Class A common stock, par value $0.00001
per share (the &ldquo;<U>Common Stock</U>&rdquo;) in consideration for you exercising for cash (i) the number of Amended and Restated
Series A Common Stock purchase warrants issued by the Company to the Holder on April 7, 2025 (the &ldquo;<U>Series A Warrants</U>&rdquo;
and the shares of Common Stock issuable upon exercise of the Series A Warrants, the &ldquo;<U>Series A Warrant Shares</U>&rdquo;) (ii)
the number of Amended and Restated Series B Common Stock purchase warrants issued by the Company to the Holder on April 7, 2025 (the
&ldquo;<U>Series B Warrants</U>&rdquo; and the shares of Common Stock issuable upon exercise of the Series B Warrants, the &ldquo;<U>Series
B Warrant Shares</U>&rdquo;) and (iii) the number of Common Stock purchase warrants issued by the Company to the Holder on April 7, 2025
(the &ldquo;<U>April Warrants</U>&rdquo; and together with the Series A Warrants and the Series B Warrants, the &ldquo;<U>Existing Warrants</U>&rdquo;
and the shares of Common Stock issuable upon exercise of the April Warrants, the &ldquo;<U>April Warrant Shares</U>&rdquo; and together
with the Series A Warrant Shares and the Series B Warrant Shares, the &ldquo;<U>Existing Warrant Shares</U>&rdquo;), all as set forth
on the signature page hereto. The Existing Warrants Shares have been registered for resale pursuant to a registration statement on Form
S-1 (File No. 333-287493) (the &ldquo;<U>Registration Statement</U>&rdquo;). The Registration Statement is currently effective and, upon
exercise of the Existing Warrants pursuant to this letter agreement, will be effective for the issuance of the Existing Warrant Shares.
Capitalized terms not otherwise defined herein shall have the meanings set forth in the New Warrants (as defined herein).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the exercise in full for cash the Existing Warrants held by the Holder at the current Exercise Price as set forth on
the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant Exercise</U>&rdquo;) on or before the Execution Time (as defined below),
the Company hereby offers to (i) sell and issue you new unregistered Common Stock purchase warrants (the &ldquo;<U>New Warrants</U>&rdquo;)
pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (&ldquo;<U>Securities Act</U>&rdquo;), to purchase up to a number
of shares (the &ldquo;<U>New Warrant Shares</U>&rdquo;) of Common Stock equal to 150% of the number of Warrant Shares issued pursuant
to the Warrant Exercise hereunder, which New Warrants shall have an exercise price per share equal to $1.08, subject to adjustment as
provided in the New Warrants, will be exercisable subject to Shareholder Approval and have a term of exercise of five (5) years from
the initial exercise date, which New Warrants shall be substantially in the form as set forth in&nbsp;<U>Exhibit A</U>&nbsp;hereto and
(ii) to amend the Series B Warrants held by the Holder and not exercised pursuant to this letter agreement in order to extend the Termination
Date (as defined in the Series B Warrants) to be equal to April 3, 2030 (the &ldquo;<U>Amended Warrants</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
New Warrant and the Amended Warrants certificates will be delivered at Closing (as defined below), and such New Warrants, together with
any underlying shares of Common Stock issued upon exercise of the New Warrants, will, unless and until their sales are registered under
the Securities Act, contain customary restrictive legends and other language typical for an unregistered warrant and unregistered shares.
Notwithstanding anything herein to the contrary, in the event that any Warrant Exercise would otherwise cause the Holder to exceed the
beneficial ownership limitations (&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;) set forth in Section 2(e) of the Existing Warrants
(or, if applicable and at the Holder&rsquo;s election, 9.99%), the Company shall only issue such number of Existing Warrant Shares to
the Holder that would not cause the Holder to exceed the maximum number of Warrant Shares permitted thereunder, as directed by the Holder,
with the balance to be held in abeyance until notice from the Holder that the balance (or portion thereof) may be issued in compliance
with such limitations, which abeyance shall be evidenced through the Existing Warrants which shall be deemed prepaid thereafter (including
the cash payment in full of the exercise price), and exercised pursuant to a Notice of Exercise in the Existing Warrants (provided no
additional exercise price shall be due and payable). The parties hereby agree that the Beneficial Ownership Limitation for purposes of
the Existing Warrants is as set forth on the Holder&rsquo;s signature page hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expressly
subject to the paragraph immediately following this paragraph below, Holder may accept this offer by signing this letter agreement below,
with such acceptance constituting Holder&rsquo;s exercise in full of the Existing Warrants for an aggregate exercise price set forth
on the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant Exercise Price</U>&rdquo;) on or before 7:00 a.m., Eastern Time, on
September 3, 2025 (the &ldquo;<U>Execution Time</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Company agrees to the representations, warranties and covenants set forth on&nbsp;<U>Annex A</U>&nbsp;attached hereto. Holder represents
and warrants that, as of the date hereof it is, and on each date on which it exercises any New Warrants it will be, an &ldquo;accredited
investor&rdquo; as defined in Rule 501 of Regulation D promulgated under the Securities Act, and agrees that the New Warrants will contain
restrictive legends when issued, and neither the New Warrants nor the shares of Common Stock issuable upon exercise of the New Warrants
will be registered under the Securities Act, except as provided in&nbsp;<U>Annex A</U>&nbsp;attached hereto. Also, Holder represents
and warrants that it is acquiring the New Warrants as principal for its own account and has no direct or indirect arrangement or understandings
with any other persons to distribute or regarding the distribution of the New Warrants or the New Warrant Shares (this representation
is not limiting Holder&rsquo;s right to sell the New Warrant Shares pursuant to an effective registration statement under the Securities
Act or otherwise in compliance with applicable federal and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder understands that issuance of the New Warrants and the New Warrant Shares are not, and may never be, registered under the Securities
Act, or the securities laws of any state and, accordingly, each certificate, if any, representing such securities shall bear a legend
substantially similar to the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THE
OFFER AND SALE OF THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates
evidencing the New Warrant Shares shall not contain any legend (including the legend set forth above), (i) while a registration statement
covering the resale of such New Warrant Shares is effective under the Securities Act, (ii) following any sale of such New Warrant Shares
pursuant to Rule 144 under the Securities Act, (iii) if such New Warrant Shares are eligible for sale under Rule 144 (assuming cashless
exercise of the New Warrants), without the requirement for the Company to be in compliance with the current public information required
under Rule 144 as to such New Warrant Shares and without volume or manner-of-sale restrictions, (iv)&nbsp;if such New Warrant Shares
may be sold under Rule 144 (assuming cashless exercise of the New Warrants) and the Company is then in compliance with the current public
information required under Rule 144 as to such New Warrant Shares, or (v) if such legend is not required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Securities and Exchange Commission
(the &ldquo;<U>Commission</U>&rdquo;) and the earliest of clauses (i) through (v), the &ldquo;<U>Delegend Date</U>&rdquo;)). The Company
shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Delegend Date if required by the Company and/or
the Transfer Agent to effect the removal of the legend hereunder, or at the request of the Holder, which opinion shall be in form and
substance reasonably acceptable to the Holder. From and after the Delegend Date, such New Warrant Shares shall be issued free of all
legends. The Company agrees that following the Delegend Date or at such time as such legend is no longer required under this Section,
it will, no later than one (1) Trading Day following the delivery by the Holder to the Company or the Transfer Agent of a certificate
representing the New Warrant Shares issued with a restrictive legend (such first (1st) Trading Day, the &ldquo;<U>Legend Removal Date</U>&rdquo;),
deliver or cause to be delivered to the Holder a certificate representing such shares that is free from all restrictive and other legends
or, at the request of the Holder shall credit the account of the Holder&rsquo;s prime broker with the Depository Trust Company System
as directed by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this offer is accepted and the transaction documents are executed by the Execution Time, then as promptly as possible following the Execution
Time, but in any event no later than 9:00 a.m., Eastern Time, on the date hereof, the Company shall issue a press release disclosing
the material terms of the transactions contemplated hereby and shall file a Current Report on Form 8-K with the Commission disclosing
all material terms of the transactions contemplated hereunder, including the filing with the Commission of this letter agreement as an
exhibit thereto within the time required by the Exchange Act. From and after the dissemination of such press release, the Company represents
to you that it shall have publicly disclosed all material, non-public information delivered to you by the Company, or any of its respective
officers, directors, employees or agents in connection with the transactions contemplated hereunder. In addition, effective upon the
dissemination of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under
any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees or Affiliates on the one hand, and you and your Affiliates on the other hand, shall terminate. The Company represents,
warrants and covenants that, upon acceptance of this offer, the Warrant Shares shall be issued at Closing free of any legends or restrictions
on resale by Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
later than the first (1st) Trading Day following the date of the public disclosure of the transactions hereunder, the closing (&ldquo;<U>Closing</U>&rdquo;)
shall occur at such location as the parties shall mutually agree. Unless otherwise directed by Roth Capital Partners, LLC (the &ldquo;<U>Placement
Agent</U>&rdquo;), settlement of the Warrant Shares shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;)
(i.e., on the Closing Date (as defined below), the Company shall issue the Warrant Shares registered in the Holder&rsquo;s name and address
provided to the Company in writing and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by
the Holder; upon receipt of such Warrant Shares, the Placement Agent shall promptly electronically deliver such Warrant Shares to the
Holder, and payment therefor shall concurrently be made to the Company by the Placement Agent (or its clearing firm) by wire transfer
to the Company). The date of the Closing of the Warrant Exercise shall be referred to as the &ldquo;<U>Closing Date</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall pay all transfer agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Existing
Warrant Shares. This letter agreement shall be construed and enforced in accordance with the laws of the State of New York, without regards
to conflicts of laws principles. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely
    yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Mobix
    labs, inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Holder
Signature Page Follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and Agreed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: __________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: ___________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Existing Warrants: __________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
Warrant Exercise Price at the current Exercise Price being exercised contemporaneously with signing this letter agreement: _________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
Warrants Beneficial Ownership Blocker: &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Warrants: _______________ (150% of the total Existing Warrants being exercised)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Warrants Beneficial Ownership Blocker: &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
Instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Holder
signature page to MOBX Inducement Offer]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations,
Warranties and Covenants of the Company</U>. The Company hereby makes the following representations and warranties to the Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SEC
    Reports</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
    under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such
    shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits
    thereto and documents incorporated by reference therein &ldquo;<U>SEC Reports</U>&rdquo;). As of their respective dates, the SEC
    Reports complied in all material respects with the requirements of the Exchange Act and none of the SEC Reports, when filed, or if
    amended, when amended, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
    therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
    </FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorization;
    Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
    by this letter agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this letter agreement
    by the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized by all necessary
    action on the part of the Company and no further action is required by the Company, its board of directors or its stockholders in
    connection herewith. This letter agreement has been duly executed by the Company and, when delivered in accordance with the terms
    hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms,
    except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other
    laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability
    of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions
    may be limited by applicable law.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Conflicts</U>. The execution, delivery and performance of this letter agreement by the Company and the consummation by the Company
    of the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company&rsquo;s certificate
    or articles of incorporation, bylaws or other organizational or charter documents; or (ii) conflict with, or constitute a default
    (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any liens, claims,
    security interests, other encumbrances or defects upon any of the properties or assets of the Company in connection with, or give
    to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of,
    any material agreement, credit facility, debt or other material instrument (evidencing Company debt or otherwise) or other material
    understanding to which such Company is a party or by which any property or asset of the Company is bound or affected; or (iii) conflict
    with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court
    or governmental authority to which the Company is subject (including federal and state securities laws and regulations), or by which
    any property or asset of the Company is bound or affected, except, in the case of each of clauses (ii) and (iii), such as could not
    have or reasonably be expected to result in a material adverse effect upon the business, prospects, properties, operations, condition
    (financial or otherwise) or results of operations of the Company, taken as a whole, or in its ability to perform its obligations
    under this letter agreement.</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
    Obligations</U>. As soon as reasonably practicable (and in any event within 30 calendar days of the date of this letter agreement)(such
    date, the &ldquo;<U>Filing Date</U>&rdquo;), the Company shall file a registration statement on Form S-3 (or other appropriate form,
    including on Form S-1, if the Company is not then S-3 eligible) providing for the resale of the New Warrant Shares by the holders
    of the New Warrants (the &ldquo;<U>Resale Registration Statement</U>&rdquo;). The Company shall use commercially reasonable efforts
    to cause the Resale Registration Statement to become effective within sixty (60) calendar days following the date hereof (or within
    90 calendar days following the date hereof in case of &ldquo;full review&rdquo; of such registration statement by the Commission)(such
    date, the &ldquo;<U>Effectiveness Date</U>&rdquo;) and to keep the Resale Registration Statement effective at all times until no
    holder of the New Warrants owns any New Warrants or New Warrant Shares. In the event that the Resale Registration Statement is not
    (i) filed by the Filing Date or (ii) declared effective by the Commission by the Effectiveness Date, then, in addition to any other
    rights the holders of New Warrants may have hereunder or under applicable law, on the Filing Date or the Effectiveness Date (each
    such date being referred to herein as an &ldquo;<U>Event Date</U>&rdquo;) and on each monthly anniversary of such Event Date (if
    the Resale Registration Statement shall not have been filed or declared effective by the applicable Event Date) until the Resale
    Registration Statement is filed or declared effective, the Company shall pay to each holder of New Warrants an amount in cash, as
    partial liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate exercise price of the New
    Warrants held by each holder of the New Warrants. If the Company fails to pay any partial liquidated damages pursuant to this Section
    in full within seven days after the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser
    maximum amount that is permitted to be paid by applicable law) to the holders of the New Warrants, accruing daily from the date such
    partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages
    pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the Resale Registration Statement
    being filed or declared effective, as the case may be.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trading
    Market</U>. The transactions contemplated under this letter agreement comply with all the rules and regulations of the Nasdaq Capital
    Market.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Filings,
    Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
    to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person
    in connection with the execution, delivery and performance by the Company of this letter agreement, other than: (i) the filings required
    pursuant to this letter agreement, (ii) application(s) or notice to each applicable Trading Market for the listing of the New Warrants
    and New Warrant Shares for trading thereon in the time and manner required thereby, (iii) the filing of Form D with the Commission,
    and (iv) such filings as are required to be made under applicable state securities laws.</FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Listing
    of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the
    Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of
    the New Warrant Shares on such Trading Market and promptly secure the listing of all of the New Warrant Shares on such Trading Market.
    The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include
    in such application all of the New Warrant Shares, and will take such other action as is necessary to cause all of the New Warrant
    Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
    necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
    reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
    of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
    without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
    with such electronic transfer.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsequent
    Equity Sales</U>. From the date hereof until the 45 days after the Closing Date, neither the Company nor any Subsidiary shall (A)
    issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents
    or (B) file any registration statement or any amendment or supplement to any existing registration statement (other than the Resale
    Registration Statement referred to herein or a registration statement on Form S-8 in connection with any employee benefit plan),
    a supplement or amendment required to be filed pursuant to the Securities Act or the rules thereunder solely to keep the information
    in a registration statement filed as of the date hereof, including an amendment or supplement to the registration statement covering
    the shares issuable pursuant to the Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC dated as of March 18,
    2024, or filing a registration statement to register the resale of shares issued or issuable pursuant to the transactions described
    in the Current Report on Form 8-K filed with the SEC on August 21, 2025. Notwithstanding the foregoing, this Section (h) shall not
    apply in respect of an Exempt Issuance. &ldquo;<U>Exempt Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or
    options to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by
    a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
    established for such purpose for services rendered to the Company, (b) warrants to the Placement Agent in connection with the transactions
    pursuant to this letter agreement and any securities upon exercise of warrants to the Placement Agent, if any, securities upon the
    exercise or exchange of or conversion of any securities issued hereunder and/or other securities exercisable or exchangeable for
    or convertible into shares of Common Stock issued and outstanding on the date of this letter agreement, provided that such securities
    have not been amended since the date of this letter agreement to increase the number of such securities or to decrease the exercise
    price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend
    the term of such securities, (c) warrants or shares to any other placement agent or financial advisor to the Company in connection
    with engagement letters outstanding on the date hereof, (d) securities issued pursuant to acquisitions or strategic transactions
    approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
    securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration
    statement in connection therewith during the prohibition period in this Section (h), and provided that any such issuance shall only
    be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner
    of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition
    to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose
    of raising capital or to an entity whose primary business is investing in securities, (e) securities issued to persons who are parties
    to the business combination agreements with RaGE Systems, Inc. and EMI Solutions, Inc. and (f) securities issuable pursuant to the
    transactions described in the Current Report on Form 8-K filed with the SEC on August 21, 2025. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Form
    D; Blue Sky Filings</U>. If required, the Company agrees to timely file a Form D with respect to the New Warrants and New Warrant
    Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Holder. The Company shall take
    such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the New Warrants
    and New Warrant Shares for, sale to the Holder at Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states
    of the United States, and shall provide evidence of such actions promptly upon request of any Holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mobix
Labs, Inc. Announces Exercise of Warrants for $4.5 Million Gross Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IRVINE,
Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) &mdash; Mobix Labs, Inc. (NASDAQ: MOBX), </B>a fabless semiconductor company delivering advanced
connectivity solutions for wired and wireless 5G, defense, aerospace, and medical applications today announced it has entered into an
agreement with a holder of its existing warrants for the immediate exercise of certain of its warrants to purchase up to an aggregate
of 5,486,467 shares of Class A common stock (&ldquo;common stock&rdquo;) of the Company at the current exercise price of $0.8202 per
share. The shares of common stock issuable upon exercise of the existing warrants are registered for resale pursuant to an effective
registration statement on Form S-1 (File No. 333-287493). The aggregate gross proceeds from the exercise of the existing warrants is
expected to total approximately $4.5 million, before deducting financial advisory fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roth
Capital Partners is acting as the Company&rsquo;s financial advisor for this transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the immediate exercise of the existing warrants for cash, the Company will issue new unregistered warrants to purchase
shares of common stock. The new warrants will be exercisable for an aggregate of up to 8,229,701 shares of common stock, at an exercise
price of $1.08 per share and will be exercisable upon stockholder approval and have a term of five years from the date of stockholder
approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction is expected to close on or about September 4, 2025, subject to satisfaction of customary closing conditions. The Company
intends to use the net proceeds from the offering for working capital and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements
of the Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;) and, along with the shares of common stock issuable upon their
exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the
Securities and Exchange Commission (&ldquo;SEC&rdquo;) or an applicable exemption from such registration requirements. The Company has
agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the
new warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Mobix Labs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
in Irvine, California, Mobix Labs is a fabless semiconductor company delivering advanced wireless and wired connectivity, RF, switching,
and filtering technologies for next-generation communication systems. Our solutions support aerospace, defense, 5G, medical, industrial,
and other high-reliability markets. We specialize in electromagnetic interference (EMI) solutions for secure aerospace GPS systems, optical
cables for high-speed interconnects, and AI datacenters, as well as mmWave radar and imaging for commercial applications, ensuring high
performance and reliability in demanding environments. Visit mobixlabs.com and follow us on LinkedIn.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking statements&rdquo; within the meaning of the federal securities laws, including Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are not historical
facts and are based on current expectations, estimates, assumptions and projections about the industry, business, strategy, and future
financial results of Mobix Labs, Inc. (the &ldquo;Company&rdquo;). Words such as &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;plans,&rdquo; &ldquo;believes,&rdquo; &ldquo;seeks,&rdquo; &ldquo;estimates,&rdquo; &ldquo;targets,&rdquo; &ldquo;projects,&rdquo;
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;continue,&rdquo; and similar
expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements
regarding the expected proceeds from, and the expected closing date of, the financing transaction described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are subject to a number of risks, uncertainties and assumptions, including but not limited to: uncertainties
associated with whether the financing transaction contemplated herein may be completed, completed with different terms, in an untimely
manner, or not at all; the Company&rsquo;s ability to find additional sources of funding to achieve its business objectives; the Company&rsquo;s
current and future capital requirements and its ability to raise additional funds to satisfy its future capital needs; the Company&rsquo;s
ability to realize the benefits of the financing transasction described herein; risks related to the Company&rsquo;s ability to successfully
manufacture, deliver, and scale its products; customer adoption, demand and deployment decisions, including by prime contractors and
government agencies; changes in defense budgets or priorities; the Company&rsquo;s ability to compete effectively; supply chain challenges;
general market and economic conditions; geopolitical risks; and the risk factors described in the Company&rsquo;s filings with the Securities
and Exchange Commission (&ldquo;SEC&rdquo;), including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.
The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future
events, or otherwise, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>mobx-20250903.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOHybP9z5Z8OekhvWB3bSn6ry0kOA0rUiJ8MBZWMQ8B -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:MOBX="http://mobixlabs.com/20250903" elementFormDefault="qualified" targetNamespace="http://mobixlabs.com/20250903">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://mobixlabs.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="mobx-20250903_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mobx-20250903_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mobx-20250903_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="MOBX_ClassCommonStockParValue0.00001PerShareMember" name="ClassCommonStockParValue0.00001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" name="RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mobx-20250903_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="mobx-20250903.xsd#Cover" roleURI="http://mobixlabs.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://mobixlabs.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="mobx-20250903.xsd#MOBX_ClassCommonStockParValue0.00001PerShareMember" xlink:label="loc_MOBXClassCommonStockParValue0.00001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MOBXClassCommonStockParValue0.00001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="mobx-20250903.xsd#MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" xlink:label="loc_MOBXRedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MOBXRedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mobx-20250903_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="mobx-20250903.xsd#MOBX_ClassCommonStockParValue0.00001PerShareMember" xlink:label="MOBX_ClassCommonStockParValue0.00001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MOBX_ClassCommonStockParValue0.00001PerShareMember" xlink:to="MOBX_ClassCommonStockParValue0.00001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MOBX_ClassCommonStockParValue0.00001PerShareMember_lbl" xml:lang="en-US">Class A Common Stock, par value $0.00001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="mobx-20250903.xsd#MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" xlink:label="MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" xlink:to="MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember_lbl" xml:lang="en-US">Redeemable warrants, each warrant exercisable for one share of Class A Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mobx-20250903_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="mobx-20250903.xsd#Cover" roleURI="http://mobixlabs.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://mobixlabs.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="mobx-20250903.xsd#MOBX_ClassCommonStockParValue0.00001PerShareMember" xlink:label="loc_MOBXClassCommonStockParValue0.00001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MOBXClassCommonStockParValue0.00001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mobx-20250903.xsd#MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" xlink:label="loc_MOBXRedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_MOBXRedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  03,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MOBIX
LABS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001855467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1591717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1
                                            Venture<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">808-8888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=MOBX_ClassCommonStockParValue0.00001PerShareMember', window );">Class A Common Stock, par value $0.00001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class
    A Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MOBX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember', window );">Redeemable warrants, each warrant exercisable for one share of Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable
    warrants, each warrant exercisable for one share of Class A Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MOBXW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=MOBX_ClassCommonStockParValue0.00001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=MOBX_ClassCommonStockParValue0.00001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mobixlabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>mobx-20250903.xsd</File>
    <File>mobx-20250903_def.xml</File>
    <File>mobx-20250903_lab.xml</File>
    <File>mobx-20250903_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "MOBX",
   "nsuri": "http://mobixlabs.com/20250903",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "mobx-20250903.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mobx-20250903_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mobx-20250903_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mobx-20250903_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 27
   },
   "report": {
    "R1": {
     "role": "http://mobixlabs.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "MOBX_ClassCommonStockParValue0.00001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mobixlabs.com/20250903",
     "localname": "ClassCommonStockParValue0.00001PerShareMember",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock, par value $0.00001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "MOBX_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mobixlabs.com/20250903",
     "localname": "RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable warrants, each warrant exercisable for one share of Class A Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://mobixlabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001493152-25-012596-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-012596-xbrl.zip
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M^5#;BPO6LIR ;;/SD:V]G7')/""4HHM3477^WO80#<"Q:2)/D-2$KR-%-"/
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M?KK7T @IN&,<.V2V[6[52-HZL?OM$]1$,R.976^S3 Q)'? ,1SE7];.G(+K
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M9@+$0CL[@T.#@VVC7V&[WDR+<0 OG\"0:.7 6H [S:1@BT8)7E/D"0^@?D-
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M-,Q'MQN/E,A&1&2'HG-BU-@QN(.3L8858)/*T;YU=1\C>J*CVTGK F4[594
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MX_QQ3.WQ690M)B7>;< G6@S*DYI_UREX:I:7<:IS0Q"%.O\;Z^4$]")RJG*
M84PI,497G=6=RIZF7\LE[U!E JW)M MAX!AVXD&"NDX^(F9.X^0R8M\JP!H_
M75.#'\]R:T'7>#F6 8HZ6"L_#D5[<]_.2^H"EV %%O$@16YZ) >R?\3W[C@.
M'YJ?K)D3_"'/'A^^,Q3GU(:NWSLC,G/.65VE!)*S[AOM@@FL!T;\-+<KF.VI
M;E0HO;1RF?M. ;?LD<X+5R"0LE+351Z:2-?+(_WM"+P%B8,O-HF#*TP<?+&N
MB8/K2NF/5<A<DXQ!(9+D2C+U40LYF,VW3P@YXBT(%@2! &:-#\OFFM,O$5R
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MDISW3SS"!$E<VXLRW.A=I&VZ59BA[<)CZL,D!(R>[Q3TQ7(^Z!RR/QSTF87
M$4BYS](10M:@\-4X*J%!*@DY09FENFOWF2:9J'D0_B1&5W M*RX&$X <:_!1
MOS!9M@ALK%(2F]M63P=LG5UP)Q0Z,()C&F6E&QJ,>9D37:O GVSI.A4-.^5D
MO_OK3,V2M'G@@\"Q8NQHPPT=6%K,L8Z'(0 [,&=(\+;4XM.-6\U.PM\J'$<_
M:F2F^U0TPA(Y&UEWQG0)S+/2R#LO=DW"M!OMK.<1R#UDDGDW71>45C\%1=P
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MF+"1@(YK529'C:P6PQ98)YBFI:%\([)MOE)1,LX$2C@IMO4\\9&'=B[=MAB
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MY3G<5&ZNLW1;-ZDKOQ;SV3 +WY[JD)$V$&Q.YQLBM<]UTS/TY>8(C*24Z9M
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MXM1!#"K&F-NJ%S3TK9 DU_MJR ;)F(\E6U]..YD6@^AA]:)'Z;U8^:0.2/4
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M<ZRIB5-J\*B3;#<MR-9K6K]* ("=10WG/YTET,Q3C5[,Z0VM77D).YII72K
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M_J)@2(3Z[F.YP6^C@+5=JS7?:G.0V[9X58=Y;5=GS3>7DM?N?7>_]O9^E<K
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M\T4^.8=SYDWS;.:10\@S_B!8!^\@2H)+,-&[G4F6S[.<OUCIS'XVF\-ZV7W
MC8+?_)>U\PJR];U>4-A;)@CQW)&ZAMU=P+'+>9IJ&U^\!?9WNIUL2@]+'_Z:
M%_CS O\]@Y[2;MGQ1O"$'BPLX03VU136/N).X3_L%SSJ!;0+ZZ.^#0\FB0>3
M%_VQ@%TEFUUMKF[G([8*4U9X832-4]@3,;0&@\0)>]H;][D7TD]]&OB\>5$
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M=0A>[9Y3$+5FIP28G]T.:.WGQF_+& ;EJYA;4!?C; OZ2C*3-R\,EAK>5H/
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MDS<=L*8D.,J: H$C?CLX'>'Y.\N#&7IK$F0#"0JODBR*K1>U6)5T"M=NQQM
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M>':^1:[K/2.]6QT3_=LV)KK&F.C?MC'1>QT3O3^G<K.'A 1"ZM9_QO%3A,7
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MU\;]]J=_S0N\'< #W)7W[8+=B$7=6[Y<V?O55G/[I'_]J->_/-N->T?WY78
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M)R9VWK%DQ)@YCJHX^H]$=DTH&V5.OT?1:I"&2A@-#!JU,LUM&$8$*"J3:BI
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MRWK-W-'56Q6$/+?4?"[U1>01.;$T$WO%58'Z:2;Y(J:IRC\ +5"UFEC3L.Z
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MW[14Q:0(>V((:SF^)*@*E^\=T:8:,]W@)$1,+ =46MEM6]S#&E-M*^=D+BD
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M*+L13I="-E%3,_"(X+Z3-7N#-^[9VAMWE]ZX9VMOW IRO7]M:O3C(B?UM>1
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M8)Q5?(//%$?;_=[&ZUUQ9TF!KW(]76RLCU;,;G/N^;(70W%PZPFXT47I$>0
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MU9N?XKB9_3@8;#-I-#76$!!I&W,@@";@>(?48WLA]'X_X;O9KX!44K[QW\R
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MG3DJF<,1"CQS")5B#W9Y%Q,XK!X#H8&:.#&IZ^>!O:&4CI>!_=O(]7AW^IS
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M;KGTM/CF(SE+++$O';8WP6%@>ED],K]'Z2Z%LI$MKG<V'L=O9-L-=)"5:O\
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MA8WUWIB @8GFGN_6#0:*&GLRH0P_D] 0BI0OSNT'\Q>F)G5%,^Z0N8ZAL19
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M'6$V2].:NT(A,= OT9CT>8=[I)PK2+D!+^O*>:6N//>URVKVDZ: #2^<@UY
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M?7.DBPXL1TH[D'WRH-&*W2SVA$YMK1NL69H[8B:1[!$'Q<(8(6E1W.695']
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MN=2@E,L7G^M2@Y<GA<[>E156:A5PMJDI.4SC^PAS7L-30J]XS<';*^F[-!&
MWZ?YJ@!RJHL97Z04@@_4@K0RUW,J,"C' Z%X:,'9X]A1/)4+[N>R)!V84_>(
MBCQ3WY"+U^>/-H_4J@_.T\FS>.HN/:V\3C?6BU@[Q]CT[QZMY+?6.R+YN\5Z
M(U-IXF@H#D9F3QZ:0^^][$DFHJ+RXX855%/,R CBW+"ZK+B#/;',\Z,Q*U)@
M _0*]U<:[D,_7F?JHX'@C8+KM0TM$>ES>N-]&<0/$H7$&O)N<1E-<%<KUEW3
MJME/<S778OJA+,#FUUQS!O?8[ A)"A3"X!.G6(+B<**RD] Y-;\VG%\)SB];
M]Q!4BD7D!(]8<;:W)DU2V/)*I7L)E6Y[<>^I"H6" .CH<*6B+:ZNDWP]5=3Z
M5QH0)>@]<(&IFZ+<"5:2446BA8<D<L8X<BA5,GZL*:#;PVF\[.C(L61(/_3.
M:+5:I/:H+U_>NI6^XHW/RQMKB\L;C_QK?Z19ZY?6\"\ 43Z]MW-UWXJT?QVO
MZ\;&PE$R5LB3Q(IQW]R*6!>"6&<RH3NSF= +0,R^H$?(3^W<\W@D V@++RNM
M$X!\+I0_)]2'H2<B<6/^=F;YG),MYPJ+QAT?IIK?PK,IZ3NL^WZ-3<K90J[O
M#=;VCI2':-X[M+M)DU60-T8\Q45;IB4@GF*<>-3=L23Y[M@EH*=RKO2+B(Z<
MSOF%U8KBN!3'<8J?5F)UP=#Y?%2'J1J+MA,6?G\6\O=P=YD=LLB;\?EP@KZD
M15NGA:>>6LVGGO.HNR\C$G>0K<_X"O\9I%3(EQ=MS1:3DNIXA:@ 1)P1;5K
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MO:EE]MJL\ZUU,<C_62I8]O'=YE'>:Y^\EZNYV;&-*?[;]P;FWO\#4$L#!!0
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M#    I$  !4   !M;V)X+3(P,C4P.3 S7VQA8BYX;6S-G5UOVS@6AN\7V/_
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MJ!DTC@>4PCF,K;9TI$H1^JIDW]WKOQT08B1,+L7/SJ%C1>@$C(91(QRERC]
M=&LMD$@I4MJW)24AP?Z2/8Y"$F60B!\[-L1_OGU@P4;1+%+4"M3<;8,#R)2L
M?7V?\SH'#.DU74B0U%BNX%.1<2@SOXCQTF!?VV^KBHVVBCJN[?2BDDV.]%HN
M-4B*7%7S!Y($/%K+.\IMY:C)K%>ZP62C[BL:OQ!H&H-)J&@=->RW9!DE*5>/
M&,H>IZ49 _2VF_Y6VWI?8!1[ 4T?AV!O40U"990CCDXIW>#XEJP9;\.G+K--
MC<FD#DM5XQ4C!F,@&ID696)'1/Q[@WE*>/S<"45#:9L+P*J.AB;SB@ZS-Q"0
M4NZ6D3N.:1+)!JP3DJ;4^N4&8+9QZ:'IO.($, =?DI1ZMZ3,[DD<RS=2,.UN
M4$QBV[3 AG5>FDJOB 'M@<RH")2'^(/-^:,<G8MA4L_"5O0NX6G8;N.G%'N+
MD.ZP)T4J#,DX1R15WH3I8*BAM$T/8%7G1I-Y18S9&\A*)D=*[QZ2<QKV0J34
MN0%$LVG&(Q=Y"$?=61<:0NT2C(LH"7"<>;D0V_3'*QU:VX" =G5(&D*O0('<
M@;!D 04S*L0I,/\AF/?#I:)T TO#JAF54N8A*+JW+DRDW@DD9QO.:Z[A'@>6
MVL*DRVS!":3S I0.<XT7K#)Y#11'/= Y3:/T6<[HN-X8WI,R2VRQ 9DKF-#W
M>\$"8$IG(),AJ4.9T$G-%T\):"KGT8#%T65V"3";K%-0UWA$@M$80,-.JZ8U
M.2'B3+1,',>7-"3;/\@S6*Z&SBX3@,TZ%)K((RK,S@ L<C%2:B3D3L"XX=$*
M\^=9%'1T%4VA730@HW4V=)5'< #6 #IR-9I=GKGL2>[P]C(4H$:+*)N2V$$)
MJ+<+2X?M.C. V"-TVAT"!(D@5(]R"=(E#1A?L\KK#F=L(QK YS,6PB.4CBB[
M4/4J0AVMUA"/ .OC$\"L%KJ7O9."F)Q)KA) ,@4GQ)V&H3A02?[/543)&"R_
M46N7KA:[=:8,0H](@MT!_.3*O>('DC%H2GV!9O*"HD[<0S/I"\W$:V@FKX'F
M[HEY LWA"XIZZ!Z:P[[0''H-S>&KH!$5[[2M.1,_I_R./9E>S@:53I!I6C4"
MLY/YATO#6Q<L,D".9V2(2TS4P&K*;SA[C&@ #YDAN1-@ --&:C2M?^B8#7;Q
M4PZ(BSBG;4TV*.\\20J9FU:F;M+<Q&0:_R"I&^ML7#*U2R1N6)+B^+_1NO5"
MW"QV@H?1L!&2FM(_5$SVNH#)8I (<G%AG>,J'V@8IY)I^ZT];3;9*A\Q5W=Z
M 8')4>-A<G[W)!/9KF;)*"<8:!'JNZU5LL%46<>5?7Y4<=-0HX;5>2TT+DYD
MN<!@?'//*/R"0%-BJZ8A<T5MZ_N]J'' E%[K2H:4SM'=>+G(66)NOBO[K/7L
MNIVR(R]V>%&[NIM&-UWLMUR;7WB4BISE.C,;FC_E,;TW".ALU7*KS:+&C2(O
M:K_-F4Y"KD5UL64L9BR.@BB-Z/*CN/CD$3:5RB2R!01LL*"AJ? "!=!68R67
M4H@*I64(;CB1$!)1$6H2H%S;DD\7"V-OWR:V!46WX0(.6.D%))WV=%A$P#"H
M1* L!*D8M]A<)LF&\!?!8PAQA!!H'@"IH?<1)\AD)U19H$NV9B38B/[Q>3R9
MWT5I8Q$ZL\1:GP28*WLD;;\7; "F=!;4/KDRX7CRT_R?J(BR7/W7[(YC^?F"
MV?-JSF)@]2FCRA8$+18+#@P2+U" ?>DT7#.42U&F=;$Z5<VLH3C:?EL &&T5
M55_;Z46EFQPU3OY:73MJ\L^WP;TP18 )"6:9[:;?9%)O_JL:+Q!H,=:X*,FE
MJ-"ZF)"PZ[*6W8. I;-!P+)C$+#T<1"P[#L(6#H;!!399DN$B'9I.H^C)086
M)VQ5VX:BQ;+.AT'J%2JP/[#-*$/0+L;VBI9JB3/YA2B^4OE?B!^&4@(Z:VM:
MMMDL%[4TB;Q@I,U98UG+;-&YBAA)M6TN-F&4DC S<Q%13(,(Q^7RB*8[XMTA
MUFCI:;X$IT/O!T/]3#9PRL**M0S+P-U2E[9OI6<O8'PA<?P'94]T1G#"* FS
M>RFF)T7M>KMOS'38KK\T XB]P*F/0^#5&1DT?)!1J C+[X0Y(>DSBS<TQ5S-
M)>>FE@G0V24'L%DG1A-Y1(K9&4!(*4:9VLT$[6SUB'*0E7WZ$BP@)+<\7;O5
MM#9KVZCUB)E6@] <[GS-C]W8.(MR-,4R)1P':?1(/N 4Y][ \D)RVY,JVTSK
MLRE-6H\0:C4(SI\L8^12,;A@RMF2,?Q,#+66K.4M<4UE?^&8AL7FVC&EQ",\
M3+Y:5I#AJ- Z86&VPG'\?I-$E"1P1Z2I[+)@M%AGH2;QB 63+X %)46%U@D+
MYRO"EZ)[^YVSI_0^7Y\5+!N@MLM&J^4Z(T:I1ZRT^0.8*4)0%E,LJ>L&GNUN
M0?%LE46XI :I96Q LQHS#9U/P$#F&K3$))#W6ZY9BNX8^I00E-X3=)Y_";FZ
M$GR6CJLOC02!G!"1C<IIB+D)H3:Q]:^.@(8;WQYI*+T J=,>_!V2,@(5(9:I
MF0J&>?4Z3IF0W](#9SMTA]@BJ*_Y@J,NO1<T]32I,Z7"ZA?7*E!]%]'E:D;5
MQ>WA(5Y-9'ED;#"H#8PK"B\8 6U!P^+JMP+<K)VWF<=1<!$S#-]EJ6DLKYC7
MM*<MEK<3>$1 TQ6T1)X2(J5T4O_O,7W@FW4:/-]P%A BW[)*RM:JZ_Y;SVB[
MS+RH2'6:>H5ZQ-E+_ ($[I) E33V*CV6RYMYE8^=JV^@)]--FL@>5!B#[X*W
M!EE^O-"C -I#AI8(C]#K81-ZX%#YHOP>RH)1)=K1]5FR6P60A.^?;\F"<#GO
MX(YLT_<BHX>6*XP>L;:OWGH71[^8ZPST L*7NH4N]1)430#-Y3MB>1+HJTP$
MJ51,WR^O;KH2O\3F8I/X:XX3(K;\'U!+ P04    " "F,"1; +IO@UL(  "4
M8P  %0   &UO8G@M,C R-3 Y,#-?<')E+GAM;-6=77/B-A2&[SO3_^#2:P(D
M[;9)-]U)V+##='=)0_:CO=D1M@!-A,1(=@+_OI(_"&!+/FR[''<OLL0<2>=]
MCBSKV)+S\M5JP8-'JC23XK+5.^FV BI"&3$QNVQ]&+>OQOWAL!7HF(B(<"GH
M94O(UJO?O_\N,/]>_M!N!P-&>701O)9A>RBF\K?@/5G0B^ -%5216*K?@H^$
M)_:('#!.5="7BR6G,35?9 U?!"].>I.@W094^Y&*2*H/=\--M?,X7NJ+3N?I
MZ>E$R$?R)-6#/@GE E;A."9QHC>U=5?=_%]6_"5GXN'"_I@030.#2^B+E6:7
M+=MNWNS3V8E4L\YIM]OK?'[W=AS.Z8*TF;#80MHJ2ME:JLKUSL_/.^FWA6G)
M<C51O&CCK%.XLZG9?,L\]EN>:':A4_?>RI#$:=1KFPF<%O:W=F'6MH?:O=/V
M6>]DI:-6 3\EJ"2G=W0:I#(OXO72]"3-;$=HY<?FBDXO6PLY69F*3G_NGG?/
M;#4_]J7IGZW 5F#"OG'7&+(5)Y,TU!W[;2>W[.PTO%144Q&G6M^: SL>T%5L
M^A.-"A]L-8 6\BI8;*WS[M(+VK9O)0O3F/F86>:>%+YP&>XTSVT,I-HE4/3G
ME+2FX<E,/G8BRCJ6BOV0XDG1F%^^I U=372L2!@7-1FO*4_K_V)L]DPZ_]JK
M*=&3M!,DNCTC9)FY1GFLBR///N8'OMCSC%HX]V3R'/0M1W/#?;M];[?C>:5V
M/2<J+"HV'W>"6>Z[N45G292IKQW.&=_T@ZF2"Q>^O$'I]5JJB"HSH':[Z+Q-
MIZ=#\U$#F&_9(G-W</7#WW(_#\!I P+0YT3KT70<R_#A:L4@<2@7^3^&HZQB
M<UI@!67;I==R09AP1Z/*MF%A<'6MO8A4*<E#\;61*%^GWXVN/V=\S01O(47:
MVBU1Z<2J>Y)>(V^I&L^-PG=T,7F^D&ZAMY4<6$==2#8CP3<*AKM+%5'X"E&E
M?O1?!NF.1M3, ,T9_(DH142L;T@XSS_?K*@*F;;?#J0:"9KZ-9KN"_"&\#]M
M 1C@,]P ?P.H_S;\!\XDB]GKO:FQ>B*Y:P&,R[<*BWN"4X2EY#$*UBO3?F1]
M&' RJ^:Z9P($VT,E6RD+"^UKJD/%EA90#>$=2^Q+QV&@*T0BC1!W=,9L.F1=
MV6CP#QF.(MAC^T&#B%<V4BBNA$@(OZ-+J6HBL&L)!/]3(\!7B43B_6="5$P5
M7T.0EXR!U']N!'6'5*Q9B9E':69!0<B7K8'H7S0"O4LL$OOQG')N;]L3 >KW
M5?9 _K\T@K];< ,B</-H)P-&#3P(6T6 <?BU<7$HR48*A4G5F8R,# 4(0LD8
MB/^\$?@=4E'!WX@(BGUC"DZH&D1]3R<2\P'3(>&91P-SK.KF]9;K%>90]KC9
M;*U>5/Y_4:+ ]+>,H>QQ$]P:K4<FWT^4VG'&.^"XK:'L<5/;.K5'AG\C8A:O
M[3*1]XGC]K(Q*UM!8>.FLRYU*)"+FQDBMNM@?*#W+:&P<;-8GTH4X'WCL")\
M*"*Z^H.N?<1+IE#DN-FK5R<*\UO%%D2MQRRL'T_*ME#JN#FK7RD*]GNR&D;&
M;39EV2*S>OK.(M @X":L(-THL1B*4*JEW+IKW9>).4/7?1EYA_V:@M"XX&:R
M!S! B<Y5%!EN.O_/*NGY8E)I#GZ*U8!(>/0VA/_I8?Q/X?QQ,]Q:O0WA?W88
M_S,X?]PLMU8O)O^^^3A2]_+)\?C<:0QECYOEUFC%))_Z/U*W2CZR;(5^'?Y2
M"6@,FI#\^E6CG@+9C #2_PM+*/@F),+5*C&!WTH=$_XW6]9-1*OMH?";D!+[
M%!_[]F;6 >Q]$==:J3T3*&C<++A2U['9VE K2MP=>M<"2A8WM:U2=62P;Z5]
M*#.7PGM;N&P%!8R;H[K4'7MPMGOAM'-4V/H:O&@/=^C=UW-DGI\4BXT'=G5W
M(O+[08X'> Y3*&?<Q-*K\\C,QY*SD,5,S-X9SQ4CO!IXE1V4-FX:Z59X9-2W
MBMJ04S-]3U>LV7VT:C2=ND9GGST4/6X66:\8-P1#K1.J#@U$12EH.' 32JCZ
M8P]!-$S,B+CNG4[N[09QQP!4LH)"QTTF7>J.#/F]O%?$OJ1BO%Y,)'?OK*DT
MA*+&31T]&H],>\>/:LY[)E#"N#ECI2ZDX>)F%<Z)F%'W8HQJ2RAIW!S2IQ)M
M?)Z!QN?9@>,S;B[I4H<$.5L[;\ZQT82S&7'OS_,6 .]5:@1ZC^9C;X],MTW9
MEQVI1>K'P'RHYN\PA9)'WHKJTWELYDG$8AIE+@V8("(T.=I&AN,&0'TI:"20
M]ZH"U:,\=_A$.?]#R"<QID1+0:,L9? ]>G 6@8:C"<\]:W2CQ.*CY(G!I=+5
ML,IQ5CA,H>R;\+S3H1-G 6JVUGMS?<K>?.=#[RH!C4 3'GSZ52,MR8NI?9<8
M>Z2O24QR#WV!<)6 !J()#T']JM$V&JB^43"3_B?_>X90[$U8&%RI$87V>$$X
MOTZT<5E[AYT]0RCM)JP KM2(0OMF0=7,C'=OE'R*Y_D>6A]U1P$H_2:L\_5J
MQHG"ZGDK?[:KT!N""FOP*R.:P-^I%NOM*&%HUX5DEWT1$>7 [[.'!J 9&UC=
MBH\<@E$\IVI[UI4Z8]WWK>&H+P4-!VXB#%6/<R'>>JN"]SJ\8P<%WX24MTHA
MS@:T9,)9.."2>.?W.V90T$W(;ROTH7"^)N)!)<LX7-\J&5)JG^OHS?D'R+"
M%4!CTX3,]R F.'<DGM]\F;X04X^2./U3 \8_[WT);SEHC)J0%$,((,V=]/.N
M.1I=K^_HE"J[V.*>KN)KT]"#?RH%* X-5#/>"07F41&OEYV20-/D@_DV_\;^
ML']#P1SY!U!+ 0(4 Q0    ( *8P)%L#;!K+P"<  /K:   *
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MB1@! &5X.3DM,2YH=&U02P$"% ,4    " "F,"1;29?:U(DD   5'@$ "P
M            @ &R) $ 9F]R;3@M:RYH=&U02P$"% ,4    " "F,"1;9Q3*
M*MX#   C#P  $0              @ %D20$ ;6]B>"TR,#(U,#DP,RYX<V10
M2P$"% ,4    " "F,"1;_DL#<@\)  #Z:   %0              @ %Q30$
M;6]B>"TR,#(U,#DP,U]D968N>&UL4$L! A0#%     @ IC D6YD\]C$7#
M I$  !4              ( !LU8! &UO8G@M,C R-3 Y,#-?;&%B+GAM;%!+
M 0(4 Q0    ( *8P)%L NF^#6P@  )1C   5              "  ?UB 0!M
J;V)X+3(P,C4P.3 S7W!R92YX;6Q02P4&      H "@!6 @  BVL!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:MOBX="http://mobixlabs.com/20250903"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mobx-20250903.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001855467</identifier>
        </entity>
        <period>
            <startDate>2025-09-03</startDate>
            <endDate>2025-09-03</endDate>
        </period>
    </context>
    <context id="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001855467</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MOBX:ClassCommonStockParValue0.00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-03</startDate>
            <endDate>2025-09-03</endDate>
        </period>
    </context>
    <context id="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001855467</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">MOBX:RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-03</startDate>
            <endDate>2025-09-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-03" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-03" id="Fact000004">0001855467</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-03" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-03" id="Fact000010">2025-09-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-03" id="Fact000011">MOBIX LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-03" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-03" id="Fact000013">001-40621</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-03" id="Fact000014">98-1591717</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-03" id="Fact000015">1                                             Venture</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-03" id="Fact000016">Suite 220</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-03" id="Fact000017">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-03" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-03" id="Fact000019">92618</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-03" id="Fact000020">(949)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-03" id="Fact000021">808-8888</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-03" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-03" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-03" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-03" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember"
      id="Fact000026">Class     A Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember"
      id="Fact000027">MOBX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-09-032025-09-03_custom_ClassCommonStockParValue0.00001PerShareMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember"
      id="Fact000029">Redeemable     warrants, each warrant exercisable for one share of Class A Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember"
      id="Fact000030">MOBXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-09-032025-09-03_custom_RedeemableWarrantsEachWarrantExercisableForOneShareOfClassCommonStockMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-03" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-09-03" id="Fact000033">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
